SANOFI-AVENTIS PROFITS RISE 53.6 PERCENT ON EXUBERA LICENCE SALE

Pharmaceutical group Sanofi-Aventis has reported that first-quarter net profit had surged by 53.6 percent with a big injection from the sale of the patent for diabetes treatment Exubera to US group Pfizer.

TODAYonline (http://www.todayonline.com/articles/116674.asp)